...
首页> 外文期刊>Neuroscience: An International Journal under the Editorial Direction of IBRO >NEW EFFECTS OF GABA(B) RECEPTOR ALLOSTERIC MODULATOR RAC-BHFF ON AMBIENT GABA, UPTAKE/RELEASE, EM AND SYNAPTIC VESICLE ACIDIFICATION IN NERVE TERMINALS
【24h】

NEW EFFECTS OF GABA(B) RECEPTOR ALLOSTERIC MODULATOR RAC-BHFF ON AMBIENT GABA, UPTAKE/RELEASE, EM AND SYNAPTIC VESICLE ACIDIFICATION IN NERVE TERMINALS

机译:GABA(B)受体变位调节剂RAC-BHFF对神经末梢环境中GABA,摄取/释放,EM和突触囊泡酸化的新影响

获取原文
获取原文并翻译 | 示例

摘要

Positive allosteric modulators of GABA(B) receptors have great therapeutic potential for medications of anxiety, depression, etc. The effects of recently discovered modulator rac-BHFF on the key characteristics of GABAergic neurotransmission were investigated in cortical and hippocampal presynaptic nerve terminals of rats (synaptosomes). The ambient level of [H-3] GABA that is a balance between release and uptake of the neurotransmitter increased significantly in the presence of rac-BHFF (at concentrations 10-30 mu M). The initial velocity of synaptosomal [H-3] GABA uptake was suppressed by the modulator. In the presence of GABA transporter blocker NO-711, it was shown that rac-BHFF increased tonic release of [H-3] GABA from synaptosomes (at concentrations 3-30 mu M). Rac-BHFF within the concentration range of 0.3-30 mu M did not enhance inhibiting effect of (+/-)-baclofen on depolarization-induced exocytotic release of [H-3] GABA. Rac-BHFF (0.3-30 mu M) caused dose-dependent depolarization of the plasma membrane and dissipation of the proton gradient of synaptic vesicles in synaptosomes that was shown in the absence/ presence of GABA(B) receptor antagonist saclofen using fluorescent dyes rhodamine 6G and acridine orange, respectively, and so, the above effects of rac-BHFF were not associated with the modulation of presynaptic GABA(B) receptors. Therefore, drug development strategy of positive allosteric modulation of GABA(B) receptors is to eliminate the above side effects of rac-BHFF in presynapse, and vice versa, these new properties of rac-BHFF may be exploited appropriately. (C) 2015 Published by Elsevier Ltd. on behalf of IBRO.
机译:GABA(B)受体的正变构调节剂具有治疗焦虑,抑郁等药物的巨大潜力。在大鼠的皮层和海马突触前神经末梢研究了最近发现的调节剂rac-BHFF对GABA能神经传递的关键特征的影响(突触小体)。在存在rac-BHFF的情况下(浓度为10-30μM),[H-3] GABA的环境水平在神经递质的释放和摄取之间达到平衡。突触体[H-3] GABA吸收的初始速度被调节剂抑制。在存在GABA转运蛋白阻滞剂NO-711的情况下,显示rac-BHFF增加了突触小体[浓度为3-30μM] [H-3] GABA的强直释放。 Rac-BHFF在0.3-30μM的浓度范围内没有增强(+/-)-baclofen对去极化诱导的[H-3] GABA胞吐释放的抑制作用。 Rac-BHFF(0.3-30μM)导致剂量依赖性膜的去极化和突触小体中突触小泡的质子梯度的耗散,这在使用荧光染料若丹明的GABA(B)受体拮抗剂沙氯芬不存在/存在下显示6G和a啶橙分别,因此,rac-BHFF的上述作用与突触前GABA(B)受体的调节无关。因此,GABA(B)受体正变构调节的药物开发策略是消除rac-BHFF在突触前的上述副作用,反之亦然,可以适当利用rac-BHFF的这些新特性。 (C)2015年由Elsevier Ltd.代表IBRO发行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号